Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AArcutis Biotherapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Arcutis Biotherapeutics, Inc.

$23.72Close · Oct 7, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement income statement flow. Revenue $129.86M. Net result $15.01M.

Income statement revenue $129.86M (+59.3% YoY).Operating income $16.43M.Pre-tax result $15.15M.Net result $15.01M.

  • ZORYVE Cream0.05: $2.93M
  • ZORYVE Cream0.15: $24.23M (+65.8% YoY)
  • ZORYVE Cream0.3: $35.33M (+27.6% YoY)
  • ZORYVE Foam: $67.38M (+71.8% YoY)
  • Research and development: $20.36M (+4.6% YoY)
  • Selling, general and administrative: $82.14M (+18.7% YoY)
  • Other expense: $1.28M (+37.6% YoY)
  • Income tax expense: $136K (-60.2% YoY)